Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Disease Outbreaks

  • your selections
Clear Search

Filter Results



  • results
Growing Global Vaccine Market Helping Spur Drug Companies To Pursue Ebola Vaccine

The New Yorker: The Race for an Ebola Vaccine “…So why this race to create an Ebola vaccine among Merck, GlaxoSmithKline, and Johnson & Johnson — three of the world’s biggest drug manufacturers? … [O]ver the past several years, companies have realized that the difficulties of making vaccines could be…

U.S. General Notes Improvement In Liberian Ebola Outbreak; U.N. Will Miss Containment Goal In Sierra Leone; Mali Records Another Case, Up To 8

Reuters reports on aspects of the Ebola epidemic in Liberia, Sierra Leone, and Mali. Reuters: ‘Dramatic improvement’ in Ebola outlook in Liberia: U.S. general “A U.S. general in the force helping Liberia fight the Ebola epidemic reported on Monday a dramatic improvement in the situation there and confirmed the cancellation…

USAID Aims To Employ Innovation, Technology To Contain Ebola Epidemic

Washington Post: USAID seeks help from ‘maker movement’ in Ebola outbreak “…About 25 teams were pitching their ideas to a panel of judges from the U.S. Agency for International Development, the Centers for Disease Control and Prevention, and the Defense Department as part of USAID’s ‘Ebola Grand Challenge’ — a…

Merck Purchasing Rights To NewLink’s Experimental Ebola Vaccine

News outlets report on a deal between pharmaceutical companies Merck and NewLink to develop, test, and market a potential Ebola vaccine. NPR: Merck Partners With NewLink To Speed Up Work On Ebola Vaccine “[Monday] NewLink Genetics said it has made a deal with drugmaker Merck to research, develop, manufacture, and…